Literature DB >> 16297644

Radiological intervention to maintain vascular access.

P Haage1, R W Günther.   

Abstract

Stenoses and thromboses of dialysis grafts and fistulae are common problems in patients with end stage renal disease (ESRD). Timely recognition and treatment of access-related complications are essential to achieve long-term access function. Minimally invasive percutaneous interventions are techniques of growing importance for the interventional community. While stenoses can typically be treated by balloon angioplasty (PTA), thrombotic lesions may necessitate the combination of mechanical devices and/or thrombolytic agents with ancillary PTA. In this article, interventional treatments for the failing arteriovenous (AV) access are presented and reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297644     DOI: 10.1016/j.ejvs.2005.10.004

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  The primary patency of percutaneous transluminal angioplasty in hemodialysis patients with vascular access failure.

Authors:  Woo Shin Kim; Wook Bum Pyun; Byung Chul Kang
Journal:  Korean Circ J       Date:  2011-09-29       Impact factor: 3.243

2.  Pictorial essay: Interventional radiology in the management of hemodialysis vascular access - A single-center experience.

Authors:  Suraj Mammen; Shyamkumar N Keshava; Vinu Moses; Surendra Babu; Santhosh Varughese
Journal:  Indian J Radiol Imaging       Date:  2012-01

3.  Development and validation of a risk score to prioritize patients for evaluation of access stenosis.

Authors:  Brad C Astor; Kim Hirschman; John Kennedy; Stan Frinak; Anatole Besarab
Journal:  Semin Dial       Date:  2021-10-12       Impact factor: 2.886

4.  Is Repeat PTA of a Failing Hemodialysis Fistula Durable?

Authors:  Ioannis Bountouris; Thorarinn Kristmundsson; Nuno Dias; Zbigniew Zdanowski; Martin Malina
Journal:  Int J Vasc Med       Date:  2014-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.